Two major Colorado hospitals have suspended all gender-affirming medical treatments for minors following direct federal regulatory pressure, marking a stunning reversal in a state that once championed radical transgender policies for children.
Story Highlights
- Denver Health and Children’s Hospital Colorado immediately halted all gender-affirming care for patients under 18
- Federal HHS regulatory actions forced the suspension, overriding Colorado’s progressive state protections
- DOJ subpoenas targeted Children’s Hospital just days before the announcement
- The move signals Trump administration’s commitment to protecting children from experimental treatments
Federal Pressure Forces Hospital Compliance
Denver Health and Children’s Hospital Colorado announced the complete suspension of medical gender-affirming care for all patients under 18, citing direct regulatory actions from the U.S. Department of Health and Human Services. The hospitals made this decision to ensure compliance with federal standards and avoid potential penalties that could jeopardize their operations and federal funding streams.
The timing reveals the effectiveness of federal oversight in protecting vulnerable children. Colorado had previously positioned itself as a sanctuary for families seeking these controversial treatments, even passing laws to shield providers from out-of-state litigation. This federal intervention demonstrates how proper regulatory authority can override misguided state policies that put children at risk.
🔥 BREAKING: Two Colorado hospitals stop all “gender affirming care” treatments for minors after being threatened by HHS; facing loss of Medicare and Medicaid funding. pic.twitter.com/BCbkCaB9On
— Gays Against Groomers (@againstgrmrs) January 3, 2026
DOJ Investigation Precedes Suspension
Children’s Hospital Colorado was actively fighting a Department of Justice subpoena for records related to gender-affirming care as recently as December 29, 2025. The hospital’s resistance to federal investigation preceded the January 3 suspension announcement by mere days, suggesting the mounting legal pressure became insurmountable. This pattern mirrors investigations into similar clinics worldwide that have faced scrutiny over experimental youth treatments.
The DOJ’s targeted approach reflects serious concerns about the evidence base supporting irreversible medical interventions on minors. Federal investigators are examining practices that have already been questioned or suspended in European countries like Sweden and Finland, where medical authorities determined these treatments lacked sufficient scientific support for children.
Protecting Children From Experimental Medicine
This suspension represents a crucial victory for child welfare and parental rights advocates who have long warned about the dangers of rushing minors into life-altering medical decisions. The hospitals’ quick compliance demonstrates how institutions prioritize federal funding over ideological agendas when faced with real consequences. Colorado families seeking these treatments will now need to travel to other states, creating natural barriers that allow for more thoughtful consideration.
The broader implications extend beyond Colorado, as this federal action could inspire similar regulatory scrutiny nationwide. Medical professionals are increasingly questioning the rushed adoption of treatments that lack long-term safety data, particularly when applied to children who cannot fully comprehend the permanent consequences of hormone therapy and surgical interventions.
Sources:
Denver Health, Children’s Hospital Colorado suspend gender-affirming care for youth
Children’s Hospital CO fights DOJ subpoena on gender-affirming care
